Detalhe da pesquisa
1.
The prevalence and impact of polypharmacy in rheumatology.
Rheumatology (Oxford)
; 62(SI3): SI237-SI241, 2023 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871915
2.
Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single-centre Australian practice.
Intern Med J
; 54(5): 838-839, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757207
3.
Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.
Rheumatology (Oxford)
; 57(1): 84-91, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29155973
4.
Update on biosimilars in rheumatology.
Inflammopharmacology
; 25(2): 177-184, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28265837
5.
Evaluating the patient with low back pain.
Practitioner
; 259(1788): 21-4, 2-3, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882775
6.
Early recognition improves prognosis in elderly onset RA. .
Practitioner
; 258(1767): 11-4, 2, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24617098
7.
Self-management pivotal in osteoarthritis.
Practitioner
; 258(1770): 25-8, 3, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24881169
8.
Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.
Circulation
; 126(21): 2473-80, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23095282
9.
Pulmonary complications of biological therapies in children and adults with rheumatic diseases.
Paediatr Respir Rev
; 14(4): 236-41, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462434
10.
Immune checkpoint inhibitor-induced lymphocytic fasciitis.
Intern Med J
; 48(12): 1550-1552, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30517989
11.
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice.
Ann Rheum Dis
; 71(12): 1950-4, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22615456
12.
Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals.
Rheumatology (Oxford)
; 51(1): 24-31, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22039226
13.
Non-infectious pulmonary toxicity of rituximab: a systematic review.
Rheumatology (Oxford)
; 51(4): 653-62, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22157468
14.
Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries.
Rheumatology (Oxford)
; 51(2): 393-6, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22210658
15.
Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review.
Clin Exp Rheumatol
; 30(6): 962-71, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23044005
16.
Interleukin-6 and cytochrome-P450, reason for concern?
Rheumatol Int
; 32(9): 2601-4, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22451032
17.
Rheumatoid arthritis and the era of biologic therapy.
Inflammopharmacology
; 20(2): 59-69, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22366810
18.
Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?
J Clin Rheumatol
; 23(2): 125-126, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28225518
19.
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2.
RMD Open
; 8(2)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701011
20.
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.
RMD Open
; 8(1)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332058